Publication dates

All regions

Cancer Therapy Industry, October 2014 Market Research & Statistics

You might be interested in: drug, oncology, hospital, more »

1-10 of about 2 100 reports for Cancer Therapy

Germany - Country Risk

  • Original Article
  • October 2012
    8 pages
  • Pathology  

    Breast Cancer  

  • Germany  

    Austria  

View report >

Palliative Care Market in Japan

  • Past, Present, and Future of Palliative Care in Japan
  • November 2012
    5 pages
  • Palliative Care  

  • Japan  

View report >

Palliative Care Market in Japan

  • Past, Present, and Future of Palliative Care in Japan
  • November 2012
    5 pages
  • Palliative Care  

  • Japan  

View report >

Clinical Trial Industry in the US

  • Nci Clinical Trials Portfolio Inventory Fy 2011
  • July 2013
    25 pages
  • Clinical Trial  

  • United States  

View report >

Hospital GDP in Iraq - Forecast

  • Iraq Healthcare Sector Overview
  • January 2012
    3 pages
  • Hospital  

  • Iraq  

    Asia  

View report >

Pathology Description in the US

  • Cancer Statistics for African Americans, 2013
  • January 2013
    16 pages
  • Cancer  

  • United States  

    North America  

View report >

Pathology Description in the US

  • Facts Spring 2014
  • April 2014
    28 pages
  • Cancer  

  • United States  

    North America  

View report >

Pharmaceutical Industry in Germany

  • January 2013
    28 pages
  • Drug  

  • Germany  

    Europe  

    World  

View report >

Pathology Description in the US

  • December 2012
    8 pages
  • Cancer  

    Hospital  

  • United States  

View report >

Pharmaceutical Industry in Germany

  • January 2012
    28 pages
  • Drug  

  • Germany  

    Europe  

View report >
13 reports for Cancer Therapy

Purchase Reports From Reputable Market Research Publishers
(From $ 75 - $ 4 995)

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy was once just a dream in the minds of physicians, clinicians ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.